{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:52:50Z","timestamp":1789433570490,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001141","name":"Australian Government Research Training Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1173361"],"award-info":[{"award-number":["1173361"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differences in opinion concerning the contribution of Mycoplasma genitalium to pelvic inflammatory disease (PID) has resulted in inconsistencies across global testing and treatment guidelines. We conducted a systematic review and meta-analysis to determine the association between M. genitalium and PID and M. genitalium positivity within PID cases to provide a contemporary evidence base to inform clinical practice (PROSPERO registration: CRD42022382156).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Medline, and Web of Science were searched to 1 December 2023 for studies that assessed women for PID using established clinical criteria and used nucleic acid amplification tests to detect M. genitalium. We calculated summary estimates of the (1) association of M. genitalium with PID (pooled odds ratio [OR]) and 2) proportion of PID cases with M. genitalium detected (pooled M. genitalium positivity in PID), using random-effects meta-analyses, with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen studies were included: 10 estimated M. genitalium association with PID, and 19 estimated M. genitalium positivity in PID. M. genitalium infection was significantly associated with PID (pooled OR = 1.67 [95% CI: 1.24\u20132.24]). The pooled positivity of M. genitalium in PID was 10.3% [95% CI: 5.63\u201315.99]. Subgroup and meta-regression analyses showed that M. genitalium positivity in PID was highest in the Americas, in studies conducted in both inpatient and outpatient clinic settings, and in populations at high risk of sexually transmitted infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>M. genitalium was associated with a 67% increase in odds of PID and was detected in about 1 of 10 clinical diagnoses of PID. These data support testing women for M. genitalium at initial PID diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciae295","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T01:24:39Z","timestamp":1717637079000},"page":"e371-e379","source":"Crossref","is-referenced-by-count":28,"title":["Systematic Review and Meta-analysis of the Association Between\n                    <i>Mycoplasma genitalium<\/i>\n                    and Pelvic Inflammatory Disease (PID)"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1754-4920","authenticated-orcid":false,"given":"Kay","family":"Htaik","sequence":"first","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-9195","authenticated-orcid":false,"given":"Lenka A","family":"Vodstrcil","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-2671","authenticated-orcid":false,"given":"Erica L","family":"Plummer","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia M","family":"Sfameni","sequence":"additional","affiliation":[{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-8085","authenticated-orcid":false,"given":"Dorothy A","family":"Machalek","sequence":"additional","affiliation":[{"name":"Centre for Women's Infectious Diseases, The Royal Women's Hospital , Parkville, VIC ,","place":["Australia"]},{"name":"The Kirby Institute, University of New South Wales, Kensington , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-7654","authenticated-orcid":false,"given":"Lisa E","family":"Manhart","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Global Health, Center for AIDS and STD, University of Washington School of Public Health , Seattle, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-5678","authenticated-orcid":false,"given":"Catriona S","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria ,","place":["Australia"]},{"name":"School of Translational Medicine, Monash University , Melbourne, Victoria ,","place":["Australia"]},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"2026031306482492300_ciae295-B1","first-page":"658","article-title":"Pelvic inflammatory disease","volume":"322","author":"Ross","year":"2001","journal-title":"BMJ"},{"key":"2026031306482492300_ciae295-B2","first-page":"S59","article-title":"Aetiology of infections associated with 1228 cases of pelvic inflammatory disease in an urban Australian sexual health clinic setting","volume":"1","author":"Goller","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026031306482492300_ciae295-B4","author":"Australian sexually transmitted infection (STI) management guidelines (AUS)"},{"key":"2026031306482492300_ciae295-B5","author":"British Association for Sexual Health and HIV (BASHH)"},{"key":"2026031306482492300_ciae295-B6","author":"Worth Health Organisatin (WHO)"},{"key":"2026031306482492300_ciae295-B7","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"2026031306482492300_ciae295-B8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/TCRM.S350750","article-title":"Management of pelvic inflammatory disease in clinical practice","volume":"19","author":"Yusuf","year":"2023","journal-title":"Ther Clin Risk Manag"},{"key":"2026031306482492300_ciae295-B9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease","volume":"72","author":"Wiesenfeld","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026031306482492300_ciae295-B10","first-page":"e112","article-title":"[The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: una guia actualizada para la publicacion de revisiones sistematicas]","volume":"46","author":"Page","year":"2022","journal-title":"Rev Panam Salud Publica"},{"key":"2026031306482492300_ciae295-B11","first-page":"113","article-title":"Criteria for diagnosis and grading of salpingitis","volume":"61","author":"Hager","year":"1983","journal-title":"Obstet Gynecol"},{"key":"2026031306482492300_ciae295-B12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462417744099","article-title":"2017 European guideline for the management of pelvic inflammatory disease","volume":"29","author":"Guideline for the management of pelvic inflammatory disease (European)","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2026031306482492300_ciae295-B13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1201\/9781003107347","volume-title":"Doing meta-analysis with R: a hands-on guide","author":"Mathias Harrer","year":"2021"},{"key":"2026031306482492300_ciae295-B14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"2026031306482492300_ciae295-B15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-2115(03)00216-1","article-title":"Planning of empirical antibiotic therapy for women with pelvic inflammatory diseases: a geographical area-specific study","volume":"111","author":"Skapinyecz","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12 Suppl 2","key":"2026031306482492300_ciae295-B16","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1093\/infdis\/jiab157","article-title":"Using innovation to address adolescent and young adult health disparities in pelvic inflammatory disease: design of the Technology Enhanced Community Health Precision Nursing (TECH-PN) trial","volume":"224","author":"Trent","year":"2021","journal-title":"Journal of Infectious Diseases"},{"key":"2026031306482492300_ciae295-B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1471-0528.2009.02455.x","article-title":"The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy","volume":"117","author":"Bjartling","year":"2010","journal-title":"Bjog"},{"key":"2026031306482492300_ciae295-B18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(02)07848-0","article-title":"Association between Mycoplasma genitalium and acute endometritis","volume":"359","author":"Cohen","year":"2002","journal-title":"Lancet"},{"key":"2026031306482492300_ciae295-B19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/OLQ.0000000000001164","article-title":"Presence and concentrations of select bacterial vaginosis-associated bacteria are associated with increased risk of pelvic inflammatory disease","volume":"47","author":"Haggerty","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/sti.2008.030486","article-title":"Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease","volume":"84","author":"Haggerty","year":"2008","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/cid\/ciy922","article-title":"Mycoplasma genitalium infections in women attending a sexually transmitted disease clinic in New Orleans","volume":"69","author":"Lillis","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"2026031306482492300_ciae295-B22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/656739","article-title":"Is Mycoplasma genitalium in women the \u201cnew Chlamydia?\u201d A community-based prospective cohort study","volume":"51","author":"Oakeshott","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026031306482492300_ciae295-B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1071\/SH14238","article-title":"Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand","volume":"13","author":"Oliphant","year":"2016","journal-title":"Sex Health"},{"key":"2026031306482492300_ciae295-B24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sti.79.2.154","article-title":"Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease","volume":"79","author":"Simms","year":"2003","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B25","doi-asserted-by":"crossref","first-page":"103872","DOI":"10.1016\/j.micpath.2019.103872","article-title":"Mycoplasma genitalium prevalence in Welsh sexual health patients: low antimicrobial resistance markers and no association of symptoms to bacterial load","volume":"139","author":"Spiller","year":"2020","journal-title":"Microb Pathog"},{"key":"2026031306482492300_ciae295-B26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/OLQ.0b013e31824b1cf3","article-title":"Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda","volume":"39","author":"Vandepitte","year":"2012","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B27","first-page":"826","article-title":"Testing for Mycoplasma genitalium in pelvic inflammatory disease: a clinical audit","volume":"4","author":"Beesley","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2026031306482492300_ciae295-B28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/sti.2005.015701","article-title":"Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis","volume":"81","author":"Cohen","year":"2005","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/sextrans-2016-052553","article-title":"Characteristics of pelvic inflammatory disease where no sexually transmitted infection is identified: a cross-sectional analysis of routinely collected sexual health clinic data","volume":"93","author":"Goller","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmjsrh-2019-200384","article-title":"High rates of treatment failure for Mycoplasma genitalium among men and women attending a sexual health clinic","volume":"46","author":"Ovens","year":"2020","journal-title":"BMJ Sex Reprod Health"},{"key":"2026031306482492300_ciae295-B31","doi-asserted-by":"crossref","first-page":"17455057221112263","DOI":"10.1177\/17455057221112263","article-title":"Factors associated with pelvic inflammatory disease: a case series analysis of family planning clinic data","volume":"18","author":"Sweeney","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"2026031306482492300_ciae295-B32","doi-asserted-by":"crossref","first-page":"102176","DOI":"10.1016\/j.jogoh.2021.102176","article-title":"Characteristics of pelvic inflammatory disease caused by sexually transmitted disease\u2014an epidemiologic study","volume":"50","author":"Yagur","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2026031306482492300_ciae295-B33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/sextrans-2018-053823","article-title":"Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis","volume":"95","author":"Cina","year":"2019","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B35","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/ije\/dyv194","article-title":"Epidemiology of Mycoplasma genitalium in British men and women aged 16\u201344 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)","volume":"44","author":"Sonnenberg","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026031306482492300_ciae295-B36","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/OLQ.0000000000001394","article-title":"Prevalence of urogenital Mycoplasma genitalium infection, United States, 2017 to 2018","volume":"48","author":"Torrone","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/OLQ.0000000000001840","article-title":"Prevalence and factors associated with Mycoplasma genitalium infection in at-risk female adolescents in Bronx county, New York","volume":"50","author":"Menezes","year":"2023","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/aje\/kws583","article-title":"Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model","volume":"178","author":"Price","year":"2013","journal-title":"Am J Epidemiol"},{"key":"2026031306482492300_ciae295-B39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","article-title":"Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial","volume":"82","author":"Ross","year":"2006","journal-title":"Sex Transm Infect"},{"key":"2026031306482492300_ciae295-B40","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/OLQ.0000000000001221","article-title":"Clearance of Mycoplasma genitalium and Trichomonas vaginalis among adolescents and young adults with pelvic inflammatory disease: results from the tech-N study","volume":"47","author":"Trent","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B41","doi-asserted-by":"crossref","first-page":"e0000623","DOI":"10.1128\/aac.00006-23","article-title":"In vitro susceptibility and resistance of Mycoplasma genitalium to nitroimidazoles","volume":"67","author":"Wood","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031306482492300_ciae295-B42","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2026031306482492300_ciae295-B43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026031306482492300_ciae295-B44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/OLQ.0000000000000352","article-title":"Assessing trends in Chlamydia positivity and gonorrhea incidence and their associations with the incidence of pelvic inflammatory disease and ectopic pregnancy in Washington state, 1988\u20132010","volume":"43","author":"Moore","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2026031306482492300_ciae295-B45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2010.02.008","article-title":"Chlamydia screening and pelvic inflammatory disease: insights from exploratory time-series analyses","volume":"38","author":"Owusu-Edusei","year":"2010","journal-title":"Am J Prev Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae295\/58426501\/ciae295.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/e371\/58426501\/ciae295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/e371\/58426501\/ciae295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:48:38Z","timestamp":1773398918000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/2\/e371\/7689270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2026,2,25]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae295","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,15]]},"published":{"date-parts":[[2024,6,7]]}}}